Clinical Trial Update: Biological Markers to Identify Early Sepsis and Acute Lung Injury

View source ↗

Summary

The clinical trial update reports the completion of a study investigating biological markers to identify early sepsis and acute lung injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Sepsis

Snippet

Sponsor: Chimei Medical Center | Conditions: Sepsis, Acute Lung Injury | Status: COMPLETED